** Shares of pharma company Jubilant Pharmova JUBA.NS rise
as much as 5.7% to 710 rupees, their highest level since July
26, 2021
** Stock eyes a third straight session of gains
** U.S. regulator Food and Drug Administration classifies
JUBA's Roorkee facility to manufacture solid dosage as Voluntary
Action Indicated (VAI)
** VAI implies the facility is in compliance with good
manufacturing practices
** Following the VAI status to Roorkee plant, JUBA says "it
expects exports from the facility to U.S. market to increase in
a meaningful manner"
** "These actions are expected to improve the gross margins
of the generics business by reducing manufacturing, quality
management and overhead costs," JUBA says in an exchange filing
** More than 700,000 shares change hands, about 1.6x the
30-day avg
** Stock up 20.7% so far YTD
(Reporting by Anisha Ajith in Bengaluru)
((anisha.ajith@thomsonreuters.com))